ClinConnect ClinConnect Logo
Search / Trial NCT06248918

Nurse-led Physical Activity Program Among Breast Cancer Survivors

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Jan 31, 2024

Trial Information

Current as of November 14, 2025

Enrolling by invitation

Keywords

Breast Cancer Survivors Physical Activity Social Cognitive Theory Health Related Quality Of Life

ClinConnect Summary

This trial, called WATSOCPAP, tests whether a nurse-led physical activity program that uses a wearable activity tracker can help women who have survived breast cancer become more active and improve their overall quality of life. It is a randomized study being conducted at Istanbul Medipol University Hospital in Istanbul, Turkey. Eligible participants are women aged 18–65 who finished active cancer treatment in the past five years, have no signs of cancer returning, currently do less than 150 minutes per week of moderate-to-vigorous activity, and have a smartphone with internet access and live in Istanbul.

Participants are randomly assigned to either the intervention or usual care. The intervention group gets a personalized exercise plan, an activity tracker, and nurse coaching based on Social Cognitive Theory for 12 weeks, starting with a face-to-face session and followed by weekly text messages and online check-ins. The control group receives standard care. All participants complete assessments at baseline, 12 weeks, and 24 weeks to measure physical activity, quality of life, weight, fatigue, and other related factors. The study is currently enrolling (NCT06248918) with an estimated completion around October 2024.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Between the ages of 18-65
  • Female gender
  • Diagnosed with stage I-III breast cancer survivors,
  • Completed active cancer primary treatment (surgery, chemotherapy, and/or radiotherapy) in the previous 5 years, excluding hormone therapy,
  • No evidence of recurrence,
  • No contraindications,
  • Less than 150 minutes of moderate-intensity physical activity or 75 minutes of vigorous-intensity physical activity per week,
  • Having a smart mobile phone and to access and use the internet,
  • Live in Istanbul city,
  • No medical condition(s) that non-adherence to an exercise program
  • Exclusion Criteria:
  • Currently pregnant or planning to become pregnant during the study period,
  • Musculoskeletal, neurological, respiratory, metabolic or cardiovascular health problems which preclude exercise,
  • Cancer recurrence and resumption of active cancer treatment.

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, Turkey

Patients applied

0 patients applied

Trial Officials

Sura Kaya, MSc

Principal Investigator

Medipol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported